Open or ongoing ALS studies from ClinicalTrials.gov that mention TDP-43, TARDBP, STMN2, UNC13A, ATXN2, PIKFYVE, monepantel or cryptic exons. Pulled October 11, 2026.
Always check eligibility and contact details on the ClinicalTrials.gov page, and discuss with your neurologist. Enrolling in one trial can rule you out of others.
“All search hits” includes studies where ClinicalTrials.gov's search matched loosely; many are not specifically about TDP-43.